NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



TCDD induces tumorigenicity in breast epithelial cells



February 2nd, 2006

2,3,7,8-Tetrachlorodibenzo-p-clioxin induces tumorigenicity in breast epithelial cells.

According to a study from South Korea, "Although 2,3,7,8-tetrachlorodibenzo-p-clioxin (TCDD) has a variety of carcinogenic and noncarcinogenic effects in experimental animals, its role in human carcinogenicity remain controversial.

"A simian virus 40-immortalized cell line from normal human breast epithelial cells with stem cells and luminal characteristic (M13SV1) was used to study whether TCDD can induce A1G positive colony formation and cause increased cell numbers in a inverted U-shaped dose-response manner."

"TCDD activated Akt, ERK2, and...


Source: Women's Health Weekly (2006-02-02)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login